Ambroxol Hydrochloride Sustained Release Tablets

Ambroxol hydrochloride sustained-release tablets are generally the metabolites of bromhexine in the body, which have the characteristics of promoting the elimination of sputum and dissolving secretions. It can promote the discharge of viscous secretions in the respiratory tract and reduce mucus retention, thereby significantly promoting sputum elimination and improving respiratory conditions. When used for treatment, the patient's mucus secretion can be restored to normal. Cough and sputum volume are usually significantly reduced, allowing the surfactant on the respiratory mucosa to perform its normal protective function. With this understanding, let's take a look at the specific effects of ambroxol hydrochloride sustained-release tablets!

1. [Functions and indications]

Applicable to acute and chronic bronchitis. Bronchial asthma. Bronchiectasis. The sputum caused by tuberculosis is thick and difficult to cough up.

2. Efficacy and indications

1. It is suitable for the expectorant treatment of acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor expectoration function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma.

2. Preventive treatment of postoperative pulmonary complications.

3. Treatment of premature infants and neonates with infant respiratory distress syndrome (IRDS).

3. Usage and Dosage

Take orally after meals. Adults take one tablet at a time, once a day.

IV. Adverse Reactions

Rarely, rash, nausea, stomach discomfort, loss of appetite, abdominal pain, and diarrhea may occur.

5. Taboo

Patients who are allergic to ambroxol hydrochloride sustained-release tablets are contraindicated. It is contraindicated for women during the first 3 months of pregnancy.

6. [Notes]

1. Use with caution in pregnant and lactating women.

2. Please consult your doctor or pharmacist for dosage for children.

3. Avoid using it simultaneously with centrally acting antitussive drugs (such as dextromethorphan) to prevent the thinned sputum from blocking the airway.

4. This product is a mucus regulator and only has a certain effect on the symptoms of coughing and sputum. When using it, you should pay attention to the causes of coughing and sputum. If there is no improvement after 7 days of use, you should seek medical attention in time.

5. If you overdose or experience serious adverse reactions, seek medical attention immediately.

6. People who are allergic to this product are forbidden to use it, and those with allergic constitution should use it with caution.

7. It is forbidden to use this product when its properties change.

8. Please keep this product out of reach of children.

9. Children must use this product under adult supervision.

10. If you are using other medicines, please consult your physician or pharmacist before using this product.

7. Ingredients

The main ingredient of this product is ambroxol hydrochloride.

8. Pharmacological Action

This product is the metabolite of bromhexine in the body, which has the characteristics of promoting the elimination of viscous sputum and dissolving secretions. It can promote the discharge of viscous secretions in the respiratory tract and reduce the retention of mucus, thereby significantly promoting sputum elimination and improving respiratory conditions. When this product is used for treatment, the patient's mucus secretion can be restored to normal. Cough and sputum volume are usually significantly reduced, allowing the surfactant on the respiratory mucosa to perform its normal protective function.

2. Toxicological effects

The toxicity index of ambroxol hydrochloride in acute toxicity tests is very low. Ames test and micronucleus test showed that ambroxol hydrochloride had no mutagenicity. Carcinogenicity studies in mice and rats showed that ambroxol hydrochloride is not carcinogenic.